Advanced Lipolytic Solution for Facial Contouring with 87% Patient Satisfaction Rate
Slim Point Face utilizes patented enzymatic lipolysis technology (KR Patent No. 1020190034567) to deliver targeted fat reduction in facial adipocytes. The synergistic combination of bromelain (8000 GDU/g), pharmaceutical-grade lecithin (95% purity), and high-potency vitamin B12 (1000mcg/ml) achieves 72% adipocyte size reduction in clinical studies. Manufactured under certification with 0.22μm sterile filtration, the formulation demonstrates 89% bioavailability in subcutaneous tissue with no systemic toxicity.